Journal of applied clinical medical physics · 2026
Introducing a novel prediction index for treatment quality of gamma knife and stereotactic-based radiotherapy: Nabaa Efficiency Index ( η Nabaa ).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alsiraj Nabaa Mohammed, Alabedi Haydar Hamza, Almusawi Mustafa Salih, Faraj Moneer K, Ahmad Rozilawati, Alzuabidi Sura Abdulkareem Madlool
Аннотация
BACKGROUND: An accurate assessment of the radiotherapy plans requires an accurate dose to the target and efficient confinement of the doses. However, present indices do not completely cover these aspects in a single framework.
PURPOSE: To develop a unified, dimensionless metric that integrates geometric conformity and dosimetric efficiency for evaluating stereotactic and fractionated radiotherapy plans aims to reduce QA workload by providing a rapid, quantitative estimate of plan acceptability, allowing early prediction of treatment plan performance.
METHODS: In this study, the Nabaa Efficiency Index η N a b a a is introduced and defined as the product of the Conformity Index (CI) and a Dose-Efficiency Ratio (DER), evaluated at 50% and 90% isodose levels ( η 50 % N a b a a , η 90 % N a b a a ). We analyzed theoretical behavior against normalized dose-volume ratios and compared η N a b a a with established indices of conformity, homogeneity, and the Paddick efficiency index ( η 50 % P a d d i c k ) . Clinical validation used 100 plans (50 Gamma Knife, 50 VMAT-SRS). Statistics included ANOVA, correlations, ROC/AUC, and decision-curve analysis.
RESULTS: η 50 % N a b a a and η 90 % N a b a a were monotonic, bounded, and dimensionless. η 50 % N a b a a distinguished gradient/halo efficiency between stereotactic and linac plans (p < 0.001). η 90 % N a b a a most strongly reflected prescription-dose conformity (pooled AUC = 0.94) and outperformed the Paddick Efficiency Index ( η 50 % P a d d i c k ) in discrimination and interpretability.
CONCLUSION: η N a b a a unifies geometric and dosimetric assessment across modalities. Its simplicity, physical interpretability, and software-ready formulation support integration into automated QA and treatment-planning pipelines.
PURPOSE: To develop a unified, dimensionless metric that integrates geometric conformity and dosimetric efficiency for evaluating stereotactic and fractionated radiotherapy plans aims to reduce QA workload by providing a rapid, quantitative estimate of plan acceptability, allowing early prediction of treatment plan performance.
METHODS: In this study, the Nabaa Efficiency Index η N a b a a is introduced and defined as the product of the Conformity Index (CI) and a Dose-Efficiency Ratio (DER), evaluated at 50% and 90% isodose levels ( η 50 % N a b a a , η 90 % N a b a a ). We analyzed theoretical behavior against normalized dose-volume ratios and compared η N a b a a with established indices of conformity, homogeneity, and the Paddick efficiency index ( η 50 % P a d d i c k ) . Clinical validation used 100 plans (50 Gamma Knife, 50 VMAT-SRS). Statistics included ANOVA, correlations, ROC/AUC, and decision-curve analysis.
RESULTS: η 50 % N a b a a and η 90 % N a b a a were monotonic, bounded, and dimensionless. η 50 % N a b a a distinguished gradient/halo efficiency between stereotactic and linac plans (p < 0.001). η 90 % N a b a a most strongly reflected prescription-dose conformity (pooled AUC = 0.94) and outperformed the Paddick Efficiency Index ( η 50 % P a d d i c k ) in discrimination and interpretability.
CONCLUSION: η N a b a a unifies geometric and dosimetric assessment across modalities. Its simplicity, physical interpretability, and software-ready formulation support integration into automated QA and treatment-planning pipelines.